PFE
Pfizer Inc. · Healthcare · Drug Manufacturers - General
Momentum inputs (comparable managers):
holder breadth +4.8% ·
share flow -0.2% ·
net new positions +4.5%
— formula
Ownership fragmentation — more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 175 | +3 | 3.07B | $73.90B | +7 | −3 |
| Q1 2026 | 174 | -2 | 3.01B | $84.42B | +3 | −6 |
| Q4 2025 | 175 | 0 | 3.18B | $79.18B | +2 | −1 |
| Q3 2025 | 25 | -1 | 1.84B | $46.80B | +1 | −3 |
| Q2 2025 | 24 | -1 | 1.79B | $43.32B | — | −1 |
| Q1 2025 | 22 | +1 | 777.51M | $19.69B | +2 | −1 |
| Q4 2024 | 21 | +2 | 779.18M | $20.66B | +2 | — |
| Q3 2024 | 18 | -2 | 507.62M | $14.68B | — | −2 |
| Q2 2024 | 20 | — | 545.09M | $15.24B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 296.97M | +2.2% | $7.53B | 0.3% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 125.65M | +4.2% | $3.18B | 0.2% | ▲ Add | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 125.65M | +4.2% | $3.18B | 0.2% | ▲ Add | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 103.49M | -26.1% | $2.62B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 103.49M | -26.1% | $2.62B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 103.49M | -26.1% | $2.62B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 103.49M | -26.1% | $2.62B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 8 | Wellington Management ✦ | 103.49M | -26.1% | $2.62B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 9 | Wellington Management ✦ | 103.49M | -26.1% | $2.62B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 10 | Wellington Management ✦ | 103.49M | -26.1% | $2.62B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 11 | Wellington Management ✦ | 103.49M | -26.1% | $2.62B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 12 | Wellington Management ✦ | 103.49M | -26.1% | $2.62B | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 13 | Norges Bank ✦ (passive) | 86.05M | -2.0% | $2.18B | 0.3% | ▼ Trim | 4 | SEC ↗ |
| 14 | Fisher Asset Management ✦ | 47.44M | +325.5% | $1.20B | 0.5% | ▲ Add | 4 | SEC ↗ |
| 15 | Capital World Investors ✦ | 27.23M | -37.6% | $689.96M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 21.62M | +14.5% | $547.74M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 21.62M | +14.5% | $547.74M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 18 | Marshall Wace ✦ | 14.09M | +81.6% | $357.02M | 0.5% | ▲ Add | 4 | SEC ↗ |
| 19 | Marshall Wace ✦ | 14.09M | +81.6% | $357.02M | 0.5% | ▲ Add | 4 | SEC ↗ |
| 20 | Arrowstreet Capital ✦ | 13.06M | New | $330.86M | 0.3% | New | 1 | SEC ↗ |
| 21 | Starboard Value ✦ | 7.73M | -49.7% | $195.90M | 3.6% | ▼ Trim | 2 | SEC ↗ |
| 22 | Millennium Management ✦ | 7.46M | +145.5% | $189.02M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 23 | Citadel Advisors ✦ | 7.03M | -52.7% | $178.26M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 24 | Citadel Advisors ✦ | 7.03M | -52.7% | $178.26M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 5.99M | -22.2% | $151.90M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 26 | D. E. Shaw & Co. ✦ | 5.99M | -22.2% | $151.90M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 6.08M | -9.3% | $150.94M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 6.08M | -9.3% | $150.94M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 6.08M | -9.3% | $150.94M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 6.08M | -9.3% | $150.94M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 6.08M | -9.3% | $150.94M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 6.08M | -9.3% | $150.94M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 6.08M | -9.3% | $150.94M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 34 | Adage Capital Partners ✦ | 2.49M | +4.6% | $63.13M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 35 | Bridgewater Associates ✦ | 1.65M | +503.8% | $41.90M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 36 | GAMCO Investors ✦ | 793.94K | +3.7% | $20.12M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 37 | Renaissance Technologies ✦ | 752.02K | New | $19.06M | 0.0% | New | 1 | SEC ↗ |
| 38 | Two Sigma Investments ✦ | 729.65K | -86.2% | $18.49M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 39 | Fairfax Financial ✦ | 650.90K | 0.0% | $16.49M | 0.9% | Held | 4 | SEC ↗ |
| 40 | Gotham Asset Management ✦ | 428.96K | +204.1% | $10.87M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 41 | Dodge & Cox ✦ | 109.71K | -1.7% | $2.78M | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Arrowstreet Capital | $330.86M | 0.3% |
| Renaissance Technologies | $19.06M | 0.0% |
Exited
| Point72 Asset Management | $43.05M | was 0.1% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 225.90K shares, $6,343 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Officer, Director · Chairman & CEO · 38.00K sh @ 26.34 · $1.00M
Open-market sales (S)
No open-market insider sales in our coverage window.
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology